These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38738531)

  • 21. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
    Webb L; Gilg J; Wilkie M
    Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COMPLETE CORRECTION OF ANEMIA WITH RECORMON® (ERYTHROPOIETIN β) IN PATIENTS ON CHRONIC HEMODIALYSIS.
    Dimković N; Mitić I; Andrić B; Lilić Havidža B; Jelačić R; Milić N
    Med Pregl; 2015; 68(9-10):324-30. PubMed ID: 26727829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis.
    Salvati F; Strippoli P; Barchetti M; Scatizzi A
    Nephron; 1992; 60(3):371. PubMed ID: 1373475
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of anemia of chronic renal failure after the treatment of hyperparathyroidism.
    Garcia-Canton C; Palomar R; Moreno A; Toledo A; Suria S; Esparza N; Rossique P; Checa MD
    Nephron; 1996; 74(2):444-5. PubMed ID: 8893180
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythropoietin and improvement of anemia in long-term hemodialysis patients.
    Dukanovic L; Clemons GK; Ikonomovski J; Biljanovic-Paunović L; Pavlović-Kentera V
    Acta Med Iugosl; 1991; 45(2):151-60. PubMed ID: 1887810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anemia and renal failure: efficacy of its control].
    Fort J
    Nefrologia; 2006; 26 Suppl 3():28-32. PubMed ID: 17469424
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythropoietin and anemia in chronic renal failure.
    Pavlović-Kentera V; Clemons GK; Djukanović L; Biljanović-Paunovic L
    Exp Hematol; 1987 Aug; 15(7):785-9. PubMed ID: 3609182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TARGT Gene Therapy Platform for Correction of Anemia in End-Stage Renal Disease.
    Blum S; Shapir N; Miari R; Lerner B; Koren B; Doenyas-Barak K; Efrati S; Pergola PE; Schwartz D; Chernin G; Yagil Y; Guzy S; Nyska A; Neil GA
    N Engl J Med; 2017 Jan; 376(2):189-191. PubMed ID: 28076704
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in therapy of renal anemia: darbepoetin alfa].
    Schaefer R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis.
    Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Nakamura S; Ikeda M; Oikawa T; Fujinami T; Kawahara H
    Nephron; 1991; 59(2):334-5. PubMed ID: 1956504
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythropoietin and improvement in the erythropoiesis of chronic hemodialysis patients treated with desferrioxamine.
    de la Serna FJ; Gilsanz F; Praga M; Estenoz J
    Clin Nephrol; 1991 Sep; 36(3):157-8. PubMed ID: 1934678
    [No Abstract]   [Full Text] [Related]  

  • 37. Chapter 7 Haemoglobin, Ferritin and Erythropoietin in UK Adult Dialysis Patients in 2016: National and.
    Pyart R; Gilg J; Williams AJ
    Nephron; 2018; 139 Suppl 1():165-190. PubMed ID: 29991003
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
    Singh AK; Milford E; Fishbane S; Keithi-Reddy SR
    Kidney Int; 2008 Sep; 74(5):679-83. PubMed ID: 18337717
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
    Fishbane S; Berns JS
    Kidney Int; 2005 Sep; 68(3):1337-43. PubMed ID: 16105069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin and iron for anemia in HIV-infected patients undergoing maintenance hemodialysis in China: a cross-sectional study.
    Peng L; He Y; Zhang J; Hong D; Li G
    BMC Nephrol; 2022 Feb; 23(1):60. PubMed ID: 35135490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.